Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

10.37 -0.04 (-0.43%)
Streaming Delayed Price Updated: 9:39 AM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fortrea Holdings Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Where Fortrea Holdings Stands With Analysts ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Earnings Scheduled For March 11, 2024 ↗
Companies Reporting Before The Bell • Ballard Power Systems (NASDAQ:BLDP) is estimated to report quarterly loss at $0.13 per share on revenue of $34.20 million. 
Via Benzinga
News headline image
Oracle, Casey's General Stores And 3 Stocks To Watch Heading Into Monday ↗
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Key Takeaways From Fortrea Holdings Analyst Ratings ↗
 
Via Benzinga
News headline image
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for February 2024 ↗
Biotech stocks are often at the forefront of innovation. These picks are worth considering for your portfolio for their growth potential. 
Via InvestorPlace
News headline image
Fortrea Increases Patient Access Capabilities and Cold Chain Expertise with FortreaRx™ Expansion
Fortrea’s non-commercial specialty pharmacy expansion delivers flexible, scalable solutions to customers and life-changing medications direct to patients 
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Expert Outlook: Fortrea Holdings Through The Eyes Of 5 Analysts ↗
 
Via Benzinga
News headline image
Where Fortrea Holdings Stands With Analysts ↗
 
Via Benzinga
News headline image
Fortrea to Present at the Barclays 26th Annual Global Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Announces Date for Fourth Quarter and Full Year 2023 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clinical Trial Experience
Companies partner to provide patients and sites with easy access to study information in one integrated solution 
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
The Latest Analyst Ratings for Fortrea Holdings ↗
 
Via Benzinga
News headline image
Why Fortrea Holdings Shares Are Gaining Today ↗
Activist hedge fund Starboard Value holds a  
Via Benzinga
News headline image
Fortrea Previews J.P. Morgan Healthcare Conference Updates
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Are November’s 3 Biggest Stock Losers Worth Snapping Up Now? ↗
The market was like an iceberg with only a few winners showing but that means there are a lot of the biggest stock losers worth getting now. 
Via InvestorPlace
News headline image
Fortrea Convenes New Site Advisory Board
Fortrea’s Site Advisory Board brings research leaders together to focus on evolving site, sponsor and patient relationships 
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Why Is Inflammation Disease Focused Acelyrin Stock Trading Lower Today? ↗
Acelyrin Inc (NASDAQ: SLRN) updated its izokibep clinical development program, including its ongoing global Phase 2b/3 trial for izokibep in  
Via Benzinga
News headline image
Fortrea Announces AI-Driven Partnership with Medidata to Increase Diversity in Clinical Trials
Collaboration leverages Medidata AI to improve access and participation of diverse population groups in clinical studies 
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Why Fortrea Holdings Stock Climbed Nearly 10% Higher Today ↗
The company's first quarter as a separate entity was better than anticipated. 
Via The Motley Fool
News headline image
Monday.Com Reports Q3 Beat, Joins Fortrea Holdings, Henry Schein And Other Big Stocks Moving Higher On Monday ↗
U.S. stocks traded lower, with the Dow Jones falling around 40 points on Monday. 
Via Benzinga
Topics Stocks
News headline image
Earnings Scheduled For November 13, 2023 ↗
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
News headline image
Fortrea Reports Third Quarter 2023 Results
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K.
Adds speed and agility with cGMP production at on-site pharmacies, adds capacity, improves flexible therapeutic capabilities and enhances experience for study volunteers 
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Starboard Value Issues Presentation Delivered at 13D Monitor’s 2023 Active-Passive Investor Summit
From Starboard Value LP
Via Business Wire
News headline image
Fortrea Appoints Life Science Executive Dr. John Doyle to Lead Consulting Team
Industry veteran brings more than three decades of experience spanning R&D, commercialization, and market access 
From Fortrea Holdings Inc
Via GlobeNewswire
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.